345 related articles for article (PubMed ID: 19826108)
21. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
22. Micrometastases in sentinel lymph nodes: few data make for hard decisions.
Rowan K
J Natl Cancer Inst; 2009 Oct; 101(20):1374-6. PubMed ID: 19797724
[No Abstract] [Full Text] [Related]
23. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
[TBL] [Abstract][Full Text] [Related]
25. Recurrence in the axilla after sentinel lymph node biopsy for breast cancer.
Salmon RJ; Bouillet TH; Lewis JS; Clough KB
Eur J Surg Oncol; 2002 Mar; 28(2):199. PubMed ID: 11884060
[No Abstract] [Full Text] [Related]
26. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
[TBL] [Abstract][Full Text] [Related]
27. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
28. The need for lymph node dissection in nonmetastatic breast cancer.
Pesce C; Morrow M
Annu Rev Med; 2013; 64():119-29. PubMed ID: 23020881
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective.
Catzeddu T; Bertelli G; Del Mastro L; Venturini M
J Surg Oncol; 2004 Mar; 85(3):129-32. PubMed ID: 14991884
[TBL] [Abstract][Full Text] [Related]
30. Failure of routine axillary nodal sampling to predict survival outcomes in lymph node-negative (N0) breast cancer.
Bland KI
Ann Surg; 2003 Feb; 237(2):168-70. PubMed ID: 12560773
[No Abstract] [Full Text] [Related]
31. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
Zhang JG; Zhong L; Li CL
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
[No Abstract] [Full Text] [Related]
33. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer.
Tan YY; Wu CT; Fan YG; Hwang S; Ewing C; Lane K; Esserman L; Lu Y; Treseler P; Morita E; Leong SP
Breast J; 2005; 11(5):338-43. PubMed ID: 16174155
[TBL] [Abstract][Full Text] [Related]
34. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
35. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
[TBL] [Abstract][Full Text] [Related]
36. Axillary staging during surgery for breast cancer.
Axelsson CK; Mouridsen HT; Düring M; Møller S
Br J Surg; 2007 Mar; 94(3):304-9. PubMed ID: 17262756
[TBL] [Abstract][Full Text] [Related]
37. Histiocytoid variant of lobular carcinoma: a triple negative case.
Omeroglu G; Holloway CM; Spayne J; Nofech-Mozes S
Breast J; 2010; 16(1):84-6. PubMed ID: 19825005
[No Abstract] [Full Text] [Related]
38. A prospective study of use of a clinicopathological score to select patients for the type of axillary surgery.
Pinkney TD; Nightingale P; Carmichael AR
Eur J Surg Oncol; 2007 Mar; 33(2):153-6. PubMed ID: 17097850
[TBL] [Abstract][Full Text] [Related]
39. [Sentinel node biopsy and invasive breast cancer: towards a new minimal surgical approach].
Nogaret JM; Hertens D; Veys I; Bourgeois P; Larsimont D
Rev Med Brux; 2002 Jun; 23(3):A175-6. PubMed ID: 12143157
[No Abstract] [Full Text] [Related]
40. [Sentinel lymph node biopsy in breast carcinoma. Can removal of the sentinel node replace axillary dissection?].
Schalhorn B
Fortschr Med; 1999 Feb; 117(5):22. PubMed ID: 10095307
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
